Related Experiment Video
Updated: Aug 26, 2026

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional
1U124 INSERM/IRCL, Place de Verdun, F-59045 Lille cedex, France and Howard Hughes Medical Institute and The Salk Institute for Biological Studies, La Jolla, CA 92037, USA. dhordain@infobiogen.fr
Abstract:
Recent works demonstrated that some transcriptional repressors recruit histone deacetylases (HDACs) either through direct interaction, or as a member of a multisubunit repressing complex containing other components referred to as corepressors. For instance, the bHLH-Zip transcriptional repressors MAD/MXI recruit HDACs together with the mSIN3 corepressors, whereas unliganded nuclear receptors contact another corepressor, SMRT (or its relative N-CoR), which, in turn, associates with both mSIN3 and HDACs to form the repressor complex. Recently, we reported that SMRT also directly associates with LAZ3(BCL-6), a POZ/Zn finger transcriptional repressor involvedin the pathogenesis of non-Hodgkin lymphomas. However, whether LAZ3 recruits the HDACs-containing repression complex is currently unknown. We report here that LAZ3 associates with corepressor mSIN3A both in vivo and in vitro , and found that a central region, which harbours autonomous repression activity, is mainly responsible for this interaction. Conversely, the N-terminal half of mSIN3A is both necessary and sufficient to bind LAZ3. Moreover, we show that LAZ3 also interacts with an HDAC (HDAC-1) through its POZ domain in vitro while the immunoprecipitation of LAZ3 results in the coretention of an endogenous HDAC activity in vivo . Finally, inhibitors of HDACs significantly reduce the LAZ3-mediated repression. Taken together, we conclude that LAZ3 recruits a repressing complex containing SMRT, mSIN3A and a HDAC, and that its full repressing potential on transcription requires HDACs activity. Our results identify HDACs as molecular targets of LAZ3 oncogene and further strengthen the connection between aberrant chromatin acetylation and human cancers.
Insights
The LAZ3 oncogene recruits histone deacetylases (HDACs) and corepressors like mSIN3A, forming a repressor complex essential for its transcriptional activity. HDAC inhibition reduces LAZ3-mediated repression, identifying HDACs as targets in cancer.
Area of Science:
- Molecular Biology
- Cancer Biology
- Epigenetics
Background:
- Transcriptional repressors often recruit histone deacetylases (HDACs) via corepressors.
- LAZ3 (BCL-6) is a transcriptional repressor implicated in non-Hodgkin lymphomas.
- The mechanism by which LAZ3 recruits HDACs was previously unknown.
Purpose of the Study:
- To investigate whether LAZ3 recruits HDACs and associated corepressors.
- To elucidate the interaction domains involved in LAZ3-corepressor binding.
- To determine the role of HDAC activity in LAZ3-mediated transcriptional repression.
Main Methods:
- In vivo and in vitro binding assays to study protein-protein interactions.
- Co-immunoprecipitation to detect endogenous complex formation.
- Treatment with HDAC inhibitors to assess functional consequences.
Main Results:
- LAZ3 directly associates with the corepressor mSIN3A through its central repression domain.
- LAZ3 interacts with HDAC-1 via its POZ domain and co-immunoprecipitates endogenous HDAC activity.
- HDAC inhibitors significantly reduce LAZ3-mediated transcriptional repression.
Conclusions:
- LAZ3 recruits a repressor complex including SMRT, mSIN3A, and HDACs.
- The transcriptional repression function of LAZ3 is dependent on HDAC activity.
- HDACs are identified as molecular targets of the LAZ3 oncogene, linking chromatin acetylation to cancer.
More Related Videos
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
10:44In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
Related Concept Videos
RNA Polymerase II Accessory Proteins
Co-activators and Co-repressors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Master Transcription Regulators
Co-activators and Co-repressors
Master Transcription Regulators